Recent News

• 01.21.2025 - Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer
• 01.14.2025 - Kyverna Therapeutics at J.P. Morgan Healthcare Conference
• 01.13.2025 - Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference
• 01.06.2025 - Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference
• 12.13.2024 - Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth

Recent Filings

• 01.24.2025 - 3 Initial statement of beneficial ownership of securities
• 01.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.21.2025 - 8-K Current report
• 01.21.2025 - EX-99.1 EX-99.1
• 11.26.2024 - S-8 Securities to be offered to employees in employee benefit plans